Enzo Biochem Ownership | Who Owns Enzo Biochem?


OverviewRevenueFinancialsChart

Enzo Biochem Ownership Summary


Enzo Biochem is owned by 24.17% institutional investors, 23.72% insiders, and 52.11% retail investors. Harbert fund advisors is the largest institutional shareholder, holding 10.11% of ENZ shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.07% of its assets in Enzo Biochem shares.

ENZ Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockEnzo Biochem24.17%23.72%52.11%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustryDiagnostics & Research Stocks47.68%7.65%44.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Harbert fund advisors5.18M10.11%$5.64M
Renaissance2.50M4.88%$2.72M
Vanguard group1.88M3.66%$2.05M
Blackrock955.02K1.86%$1.04M
Geode capital management356.90K0.70%$389.14K
Dimensional fund advisors lp340.33K0.66%$370.96K
Rbf capital250.36K0.49%$272.89K
State street154.14K0.30%$168.01K
Bridgeway capital management132.10K0.26%$143.99K
Wittenberg investment management117.14K0.23%$127.68K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Harbert fund advisors5.18M4.01%$5.64M
Nierenberg investment management company88.56K0.05%$96.53K
Wittenberg investment management117.14K0.04%$127.68K
Tls advisors13.62K0.04%$14.00K
Rbf capital250.36K0.02%$272.89K
Kempner capital management25.48K0.01%$28.00K
Renaissance2.50M0.00%$2.72M
Shulman demeo asset management15.49K0.00%$16.88K
Bridgeway capital management132.10K0.00%$143.99K
Covestor3.97K0.00%$4.00K

Top Buyers

HolderShares% AssetsChange
Nierenberg investment management company88.56K0.05%77.00K
Renaissance2.50M0.00%64.42K
Lazard asset management50.45K0.00%50.45K
Wittenberg investment management117.14K0.04%49.13K
Citadel advisors34.00K-34.00K

Top Sellers

HolderShares% AssetsChange
Tang capital management---1.26M
Dimensional fund advisors lp340.33K0.00%-315.46K
Bridgeway capital management132.10K0.00%-95.00K
Susquehanna group, llp---24.27K
Assenagon asset management---19.77K

New Positions

HolderShares% AssetsChangeValue
Citadel advisors34.00K-34.00K$37.06K
Manufacturers life insurance company, the14.96K-14.96K$16.30K
Tls advisors13.62K0.04%13.62K$14.00K

Sold Out

HolderChange
Newedge advisors-10.00
Sage mountain advisors-14.20K
Pfg investments-18.66K
Paradigm financial partners-19.50K
Assenagon asset management-19.77K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202439-2.50%12,380,058-10.44%243.23%1344.44%9-18.18%
Mar 31, 202440-13.04%13,822,593-15.48%272.61%9-50.00%1122.22%
Dec 31, 2023469.52%16,355,143-1.36%322.97%1850.00%9-10.00%
Sep 30, 202342-16.00%16,580,621-11.98%332.21%12-20.00%10-16.67%
Jun 30, 202350-10.71%18,838,041-5.02%382.40%15-21.05%12-29.41%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.19M2.07%-
Vanguard Institutional Extnd Mkt Idx Tr618.88K1.08%-
Fidelity Extended Market Index221.22K0.38%10.90K
Bridgeway Ultra-Small Company Market126.50K0.25%-95.00K
iShares Micro-Cap ETF99.80K0.19%-
BlackRock Extended Equity Market K78.20K0.15%-33.00
Dimensional US Targeted Value ETF81.91K0.14%-
Dimensional US Core Equity 2 ETF58.63K0.10%-
Fidelity Total Market Index55.55K0.10%-
Fidelity Series Total Market Index52.37K0.09%-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 10, 2023Wolf James G.-Buy$6.45K
Feb 13, 2023Wolf James G.-Buy$6.45K
Feb 13, 2023Wolf James G.-Buy$1.88K
Feb 13, 2023Wolf James G.-Sell$1.62K
Feb 13, 2023Wolf James G.-Buy$6.42K

Insider Transactions Trends


DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q3--

ENZ Ownership FAQ


Who Owns Enzo Biochem?

Enzo Biochem shareholders are primarily institutional investors at 24.17%, followed by 23.72% insiders and 52.11% retail investors. The average institutional ownership in Enzo Biochem's industry, Diagnostics & Research Stocks, is 47.68%, which Enzo Biochem falls below.

Who owns the most shares of Enzo Biochem?

Enzo Biochem’s largest shareholders are Harbert fund advisors (5.18M shares, 10.11%), Renaissance (2.5M shares, 4.88%), and Vanguard group (1.88M shares, 3.66%). Together, they hold 18.65% of Enzo Biochem’s total shares outstanding.

Does Blackrock own Enzo Biochem?

Yes, BlackRock owns 1.86% of Enzo Biochem, totaling 955.02K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.04M$. In the last quarter, BlackRock increased its holdings by 1.03K shares, a 0.11% change.

Who is Enzo Biochem’s biggest shareholder by percentage of total assets invested?

Harbert fund advisors is Enzo Biochem’s biggest shareholder by percentage of total assets invested, with 4.01% of its assets in 5.18M Enzo Biochem shares, valued at 5.64M$.

Who is the top mutual fund holder of Enzo Biochem shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Enzo Biochem shares, with 2.07% of its total shares outstanding invested in 1.19M Enzo Biochem shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools